https://www.selleckchem.com/pr....oducts/donafenib-sor
Both conventional and novel cancer therapies can adversely affect the nervous system, thereby producing a wide range of neurologic complications. Increased awareness among neurologists and early recognition of cancer therapy-induced neurotoxic syndromes is critically important to minimize patient morbidity, prevent permanent injury, and improve patient outcomes. Neurologic complications in patients with cancer can significantly impact morbidity and mortality. Although these complications can be seen in patients without ca